Hear why SCIg may be a better option for long-term treatment of patients on Immunoglobulin therapy with difficult venous access.
Hear the results of a study to understand wear-off effects in CIDP patients during IVIg therapy.
Gain an understanding of the existing surveillance data, studies and facts associated with the influenza vaccine as it relates to GBS and CIDP.
Find out what pathogenic processes are involved in acute and chronic inflammatory neuropathies, including GBS, CIDP, and MMN.
Learn how an algorithm could be used to personalize dosing schedules for IVIg.
Learn more about the mechanism of action, symptoms, diagnosis, and treatment of CIDP.
Hear the results of a trial to determine the feasibility of switching patients with multifocal motor neuropathy on intravenous to subcutaneous immunoglobulin.
Learn more about the features, symptoms, diagnosis, and treatment of GBS.
Hear why SCIg may be a better option for long-term treatment of patients on Immunoglobulin therapy with difficult venous access.
Hear the results of a study to understand wear-off effects in CIDP patients during IVIg therapy.
Gain an understanding of the existing surveillance data, studies and facts associated with the influenza vaccine as it relates to GBS and CIDP.
Find out what pathogenic processes are involved in acute and chronic inflammatory neuropathies, including GBS, CIDP, and MMN.
Learn how an algorithm could be used to personalize dosing schedules for IVIg.
Learn more about the mechanism of action, symptoms, diagnosis, and treatment of CIDP.
Hear the results of a trial to determine the feasibility of switching patients with multifocal motor neuropathy on intravenous to subcutaneous immunoglobulin.
Learn more about the features, symptoms, diagnosis, and treatment of GBS.
Hear why SCIg may be a better option for long-term treatment of patients on Immunoglobulin therapy with difficult venous access.
Hear the results of a study to understand wear-off effects in CIDP patients during IVIg therapy.
Gain an understanding of the existing surveillance data, studies and facts associated with the influenza vaccine as it relates to GBS and CIDP.
Find out what pathogenic processes are involved in acute and chronic inflammatory neuropathies, including GBS, CIDP, and MMN.
Learn how an algorithm could be used to personalize dosing schedules for IVIg.
Learn more about the mechanism of action, symptoms, diagnosis, and treatment of CIDP.
Hear the results of a trial to determine the feasibility of switching patients with multifocal motor neuropathy on intravenous to subcutaneous immunoglobulin.
Learn more about the features, symptoms, diagnosis, and treatment of GBS.
Hear why SCIg may be a better option for long-term treatment of patients on Immunoglobulin therapy with difficult venous access.
Hear the results of a study to understand wear-off effects in CIDP patients during IVIg therapy.
Gain an understanding of the existing surveillance data, studies and facts associated with the influenza vaccine as it relates to GBS and CIDP.
Find out what pathogenic processes are involved in acute and chronic inflammatory neuropathies, including GBS, CIDP, and MMN.
Learn how an algorithm could be used to personalize dosing schedules for IVIg.
Learn more about the mechanism of action, symptoms, diagnosis, and treatment of CIDP.
Hear the results of a trial to determine the feasibility of switching patients with multifocal motor neuropathy on intravenous to subcutaneous immunoglobulin.
Learn more about the features, symptoms, diagnosis, and treatment of GBS.